Predicting Patient Relapse With 80% Accuracy: AI-Powered Behavioral Health Insights

AI-driven relapse rate prediction enhanced treatment customization and improved patient outcomes in behavioral health.

4%

quarter-on-quarter revenue growth due to customized treatment plans

85,000

Users: The mobile app rollout successfully engaged patients, improving access to healthcare services.

30%

Data issues resolved: Turing streamlined admission and data-capturing processes by addressing untrainable data inefficiencies.

IndustryHealthcare & Life Sciences
Company typeEnterprise
CountryUnited States
Services usedTuring Intelligence
Predicting Patient Relapse With 80% Accuracy AI-Powered Behavioral Health Insights

About the client

A leading healthcare company with a broad network of behavioral health facilities across the United States, focused on treating behavioral health and addiction disorders.

The problem

The client needed an accurate ML model to predict patient relapse rates effectively, allowing for more tailored treatment plans and efficient resource allocation.

The solution

The client, with support from Turing, implemented a comprehensive machine learning (ML) framework to tackle the challenge:

  • Data labeling and feature engineering: Collaborated with Turing to clearly define relapse categories and develop labels. The team analyzed five years of patient data and identified 120 features that could impact prediction outcomes.
  • Model training and optimization: The team trained and tested various classifier algorithms, selecting GBTClassifier for its accuracy and lesser tendency to overfit. Anti-overfitting techniques were employed, and the model was tuned to achieve the target ROC/AUC score of 0.8.
  • Implementation and deployment: After refining the model, Turing deployed it on the client’s systems via Azure Cloud, ensuring real-time application and testing on live patients.

The result

  • 4% quarter-on-quarter revenue growth: Achieved through the introduction of customized treatment plans based on relapse predictions.
  • Improved treatment customization: Additional data flags like "Discontinued" and "Treatment plan not followed" allowed the client to devise more tailored treatment plans.
  • Enhanced predictive accuracy: The model provided accurate relapse predictions at the admission stage, supporting better patient outcomes and resource allocation.

Want to innovate your business with AI/ML?

Talk to one of our solutions experts and start your AI/ML transformation.

Get Started

Share

Want to accelerate your business with AI?

Talk to one of our solutions architects and start innovating with AI-powered talent.

Get Started